drugset / Trial / NCT02550444

Intrathecal Clonidine in Cesarean Section May Lead to Worse Blood Gas Results in the Newborns

NCT02550444 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate effects of intravenous clonidine in acute and chronic post-cesarean pain, possible adverse effects over mother-newborn pair, in comparison to intrathecal adjuvant clonidine and placebo.

Timeline

Start
2015-04
Primary completion
2015-05
Completion
2016-06

Outcome

Missed primary endpoint

paper No differences in postoperative pain scores were found (Numerical Verbal Scale for pain at movement at 24 hours of postcesarean delivery: 4.53 ± 3.0 vs 4.45 ± 2.73 vs 3.93 ± 3.07 for control, intrathecal, and intravenous, respectively, P = .771). PMID 29596102 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified 75 ug Intrathecal

Indications